03/19/2025
4:10 PM | Immunome (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/19/2025
3:11 PM | Immunome (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
11:35 AM | Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
4:44 PM | Immunome Aggregator, LP (Filed by)
Immunome (Subject)
| Form SCHEDULE 13D/A | |
02/03/2025
8:01 PM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:08 PM | Immunome (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/30/2025
8:57 PM | Immunome (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/30/2025
3:24 PM | Immunome (Filer)
| Form 424B5 | |
01/30/2025
3:28 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
3:29 PM | Immunome (Filer)
| Form 424B5 | |
01/23/2025
3:01 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for IMNM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immunome and its competitors with MarketBeat's FREE daily newsletter. |
11/25/2024
7:35 AM | Immunome (Issuer)
Lechleider Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
7:41 AM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
7:33 AM | Immunome (Issuer)
Tsai Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Immunome (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
9:33 AM | Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
11/13/2024
3:06 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
2:57 PM | Immunome (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:54 AM | Immunome (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/29/2024
7:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Immunome (Subject)
| Form SC 13G | |
10/08/2024
3:31 PM | Immunome (Filer)
| Form S-3ASR | |
10/07/2024
6:14 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
6:26 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
1:18 PM | Immunome (Subject)
Rosett Max (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
8:05 PM | Higgins Jack (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
8:07 PM | BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
2:21 PM | Higgins Jack (Reporting)
Immunome (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
4:48 PM | Immunome (Issuer)
Turner Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:51 PM | Horn Kinney (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:54 PM | Immunome (Issuer)
Stoneman Sandra G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:56 PM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:36 PM | Higgins Jack (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:40 PM | Immunome (Issuer)
Lechleider Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
4:43 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:10 PM | Immunome (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/18/2024
7:52 PM | BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:54 PM | Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:56 PM | Immunome (Issuer)
SWAIN SANDRA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:59 PM | Immunome (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:01 PM | Boylan James P (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Elon put $51 million into this (Ad) Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists [See The Details Here] |
06/18/2024
8:05 PM | Immunome (Issuer)
Tsai Philip (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2024
8:08 PM | Immunome (Issuer)
Tsai Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:48 PM | Barchas Isaac (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:05 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:49 PM | BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:13 PM | Immunome (Issuer)
SIEGALL CLAY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:11 PM | Immunome (Issuer)
Rosett Max (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
7:48 AM | Immunome (Filer)
| Form 424B5 | |
05/14/2024
7:05 AM | Immunome (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
7:02 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
7:14 PM | Immunome (Issuer)
SWAIN SANDRA M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
7:12 PM | Immunome (Issuer)
SWAIN SANDRA M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/26/2024
3:12 PM | Immunome (Filer)
| Form ARS | |
04/25/2024
3:01 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
3:40 PM | Immunome (Filer)
| Form S-3ASR | |
03/28/2024
3:04 PM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | Immunome (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
7:05 AM | Immunome (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy IMNM Stock Free IMNM Stock Alerts